Pdt Partners, LLC Verrica Pharmaceuticals Inc. Transaction History

Pdt Partners, LLC

  • $1.01 Billion
  • Q1 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2022

May 16, 2022
SELL
$7.59 - $9.49 $81,972 - $102,492
-10,800 Closed
0 $0
Q4 2021

Feb 14, 2022
BUY
$9.1 - $13.36 $98,280 - $144,288
10,800 New
10,800 $99,000
Q3 2021

Nov 15, 2021
SELL
$9.55 - $13.96 $154,710 - $226,152
-16,200 Closed
0 $0
Q2 2021

Aug 16, 2021
BUY
$9.77 - $15.33 $158,274 - $248,346
16,200 New
16,200 $183,000

Others Institutions Holding VRCA

# of Institutions
61
Shares Held
16.2M
Call Options Held
0
Put Options Held
0
View Full List

About Verrica Pharmaceuticals Inc.

VRCA Quotes by TradingView
  • Ticker VRCA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 41,094,100
  • Market Cap $300M
  • Description
  • Verrica Pharmaceuticals Inc., a dermatology therapeutics company, develops and commercializes treatments for people with skin diseases in the United States. The company's lead product candidate includes VP-102 for the treatment of molluscum contagiosum; that has completed Phase II clinical trial for the treatment of external genital warts; and w...
More about VRCA
Track This Portfolio

Track Pdt Partners, LLC Portfolio

Follow Pdt Partners, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Pdt Partners, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Pdt Partners, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email